Eli Lilly and Co (NYSE:LLY)

82.77
Delayed Data
As of May 25
 +0.06 / +0.07%
Today’s Change
73.69
Today|||52-Week Range
89.09
-2.00%
Year-to-Date

Today’s Trading

Previous close82.71
Today’s open82.79
Day’s range82.59 - 83.47
Volume2,338,143
Average volume (3 months)4,716,343
Market cap$90.2B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-107.36%
Earnings growth (this year)+20.02%
Earnings growth (next 5 years)+9.82%
Revenue growth (last year)+7.77%
P/E ratio77.4
Price/Sales3.88
Price/Book7.88

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.14-0.22%
NVONovo Nordisk-0.37-0.77%
BMYBristol-Myers Squibb+0.08+0.15%
GSKGlaxoSmithKline-0.18-0.45%
Data as of 4:02pm ET, 05/25/2018

Financials

Next reporting dateJuly 24, 2018
EPS forecast (this quarter)$1.29
Annual revenue (last year)$22.9B
Annual profit (last year)-$204.1M
Net profit margin-0.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP-Biotechnology &
Autoimmunity Research
Thomas F. Bumol
Corporate headquarters
Indianapolis, Indiana

Forecasts